+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Alcohol Addiction - Pipeline Insight, 2025 - Product Thumbnail Image

Alcohol Addiction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lung Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acinetobacter Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Acinetobacter Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epithelial Ovarian Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Cathepsin S Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cathepsin S Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Caspases Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Caspases Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Thrombocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Thrombocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Tardive Dyskinesia - Pipeline Insight, 2025 - Product Thumbnail Image

Tardive Dyskinesia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Systemic Mastocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Mastocytosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Resistant Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Resistant Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renal Anemia- Pipeline Insight, 2025 - Product Thumbnail Image

Renal Anemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator